T266M variants of ANGPTL4 improve lipid metabolism by modifying their binding affinity to acetyl-CoA carboxylase in obstructive sleep apnea

References

• Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1–12. doi: 10.1056/NEJM199304293281704.
   PubMed Web of Science ®Google Scholar
• Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383(9918):736–747. doi: 10.1016/S0140-6736(13)60734-5.
   PubMed Web of Science ®Google Scholar
• Lévy P, Kohler M, McNicholas WT, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015;1(1):15015. doi: 10.1038/nrdp.2015.15.
   PubMed Web of Science ®Google Scholar
• Barros D, García-Río F. Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence. Sleep. 2019;42(3): zsy236. doi: 10.1093/sleep/zsy236.
   PubMed Web of Science ®Google Scholar
• Meszaros M, Bikov A. Obstructive sleep apnoea and lipid metabolism: the summary of evidence and future perspectives in the pathophysiology of OSA-associated dyslipidaemia. 2022.
   Google Scholar
• Guan J, Yi H, Zou J, et al. Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study. Thorax. 2016;71(4):347–355. doi: 10.1136/thoraxjnl-2015-207403.
   PubMed Web of Science ®Google Scholar
• Zhu P, Goh YY, Chin HF, et al. Angiopoietin-like 4: a decade of research. Biosci Rep. 2012;32(3):211–219. doi: 10.1042/BSR20110102.
   PubMed Web of Science ®Google Scholar
• Zhang R. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biol. 2016;6(4):150272. doi: 10.1098/rsob.150272.
   PubMed Web of Science ®Google Scholar
• Grootaert C, Van de Wiele T, Verstraete W, et al. Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationships. Expert Rev Proteomics. 2012;9(2):181–199. doi: 10.1586/epr.12.12.
   PubMed Web of Science ®Google Scholar
• Muendlein A, Saely CH, Leiherer A, et al. Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients. Atherosclerosis. 2014;237(2):632–638. doi: 10.1016/j.atherosclerosis.2014.10.028.
   PubMed Web of Science ®Google Scholar
• Desai U, Lee E-C, Chung K, et al. Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc Natl Acad Sci U S A. 2007;104(28):11766–11771. doi: 10.1073/pnas.0705041104.
   PubMed Web of Science ®Google Scholar
• Drager LF, Li J, Shin M-K, et al. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J. 2012;33(6):783–790. doi: 10.1093/eurheartj/ehr097.
   PubMed Web of Science ®Google Scholar
• Le Jan S, Amy C, Cazes A, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol. 2003;162(5):1521–1528. doi: 10.1016/S0002-9440(10)64285-X.
   PubMed Web of Science ®Google Scholar
• Al-Terki A, Abu-Farha M, AlKhairi I, et al. Increased level of angiopoietin like proteins 4 and 8 in people with sleep apnea. Front Endocrinol (Lausanne). 2018;9:651. doi: 10.3389/fendo.2018.00651.
   PubMed Web of Science ®Google Scholar
• Romeo S, Pennacchio LA, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet. 2007;39(4):513–516. doi: 10.1038/ng1984.
   PubMed Web of Science ®Google Scholar
• van Leeuwen EM, Sabo A, Bis JC, et al. Meta-analysis of 49 549 individuals imputed with the 1000 genomes project reveals an exonic damaging variant in ANGPTL4 determining fasting TG levels. J Med Genet. 2016;53(7):441–449. doi: 10.1136/jmedgenet-2015-103439.
   PubMed Web of Science ®Google Scholar
• Talmud PJ, Smart M, Presswood E, et al. ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk. Arterioscler Thromb Vasc Biol. 2008;28(12):2319–2325. doi: 10.1161/ATVBAHA.108.176917.
   PubMed Web of Science ®Google Scholar
• Abid K, Trimeche T, Mili D, et al. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in type 2 diabetic Tunisian population. Lipids Health Dis. 2016;15(1):63. doi: 10.1186/s12944-016-0231-6.
   PubMedGoogle Scholar
• Staiger H, Machicao F, Werner R, et al. Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. Metabolism. 2008;57(5):637–643. doi: 10.1016/j.metabol.2007.12.007.
   PubMed Web of Science ®Google Scholar
• Brownsey RW, Boone AN, Elliott JE, et al. Regulation of acetyl-CoA carboxylase. Biochem Soc Trans. 2006;34(Pt 2):223–227. doi: 10.1042/BST20060223.
   PubMedGoogle Scholar
• Munday MR, Hemingway CJ. The regulation of acetyl-CoA carboxylase–a potential target for the action of hypolipidemic agents. Adv Enzyme Regul. 1999;39(1):205–234. doi: 10.1016/s0065-2571(98)00016-8.
   PubMedGoogle Scholar
• Chang H, Kwon O, Shin MS, et al. Role of Angptl4/fiaf in exercise-induced skeletal muscle AMPK activation. J Appl Physiol (1985). 2018;125(3):715–722. doi: 10.1152/japplphysiol.00984.2016.
   PubMed Web of Science ®Google Scholar
• Xu J, Chen WJ, Wang Z, et al. Profiles of transcriptome and metabolic pathways after hypobaric hypoxia exposure. Proteome Sci. 2022;20(1):16. doi: 10.1186/s12953-022-00198-y.
   PubMed Web of Science ®Google Scholar
• Wang D, Buja LM, McMillin JB. Acetyl coenzyme a carboxylase activity in neonatal rat cardiac myocytes in culture: citrate dependence and effects of hypoxia. Arch Biochem Biophys. 1996;325(2):249–255. doi: 10.1006/abbi.1996.0031.
   PubMed Web of Science ®Google Scholar
• Hazlehurst JM, Lim TR, Charlton C, et al. Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents. Metabol Open. 2022;14:100177. doi: 10.1016/j.metop.2022.100177.
   PubMedGoogle Scholar
• Li J, Grigoryev DN, Ye SQ, et al. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol (1985). 2005;99(5):1643–1648. doi: 10.1152/japplphysiol.00522.2005.
   PubMed Web of Science ®Google Scholar
• Xu H, Liu F, Li Z, et al. Genome-wide association study of obstructive sleep apnea and objective sleep-related traits identifies novel risk loci in han chinese individuals. Am J Respir Crit Care Med. 2022;206(12):1534–1545. doi: 10.1164/rccm.202109-2044OC.
   PubMed Web of Science ®Google Scholar
• Iber C, Ancoli-Israel S, Chesson A, et al. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westche-ster (IL): American Academy of Sleep Medicine 2007.
   Google Scholar
• Jordan SD, Könner AC, Brüning JC. Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis. Cell Mol Life Sci. 2010;67(19):3255–3273. doi: 10.1007/s00018-010-0414-7.
   PubMed Web of Science ®Google Scholar
• Ness GC. Physiological feedback regulation of cholesterol biosynthesis: role of translational control of hepatic HMG-CoA reductase and possible involvement of oxylanosterols. Biochim Biophys Acta. 2015;1851(5):667–673. doi: 10.1016/j.bbalip.2015.02.008.
   PubMed Web of Science ®Google Scholar
• González-Muniesa P, de Oliveira C, Pérez de Heredia F, et al. Fatty acids and hypoxia stimulate the expression and secretion of the adipokine ANGPTL4 (angiopoietin-like protein 4/fasting-induced adipose factor) by human adipocytes. J Nutrigenet Nutrigenomics. 2011;4(3):146–153. doi: 10.1159/000327774.
   PubMedGoogle Scholar
• Yao Q, Shin MK, Jun JC, et al. Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues. J Lipid Res. 2013;54(4):1058–1065. doi: 10.1194/jlr.M034272.
   PubMed Web of Science ®Google Scholar
• Drager LF, Yao Q, Hernandez KL, et al. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am J Respir Crit Care Med. 2013;188(2):240–248. doi: 10.1164/rccm.201209-1688OC.
   PubMed Web of Science ®Google Scholar
• Xu A, Lam MC, Chan KW, et al. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A. 2005;102(17):6086–6091. doi: 10.1073/pnas.0408452102.
   PubMed Web of Science ®Google Scholar
• Ge H, Yang G, Yu X, et al. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J Lipid Res. 2004;45(11):2071–2079. doi: 10.1194/jlr.M400138-JLR200.
   PubMed Web of Science ®Google Scholar
• Köster A, Chao YB, Mosior M, et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology. 2005;146(11):4943–4950. doi: 10.1210/en.2005-0476.
   PubMed Web of Science ®Google Scholar
• Smart-Halajko MC, Kelley-Hedgepeth A, Montefusco MC, et al. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in non-Hispanic white Americans from the look AHEAD clinical trial. BMC Med Genet. 2011;12(1):89. doi: 10.1186/1471-2350-12-89.
   PubMedGoogle Scholar
• Smart-Halajko MC, Robciuc MR, Cooper JA, et al. The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk. Arterioscler Thromb Vasc Biol. 2010;30(11):2277–2282. doi: 10.1161/ATVBAHA.110.212209.
   PubMed Web of Science ®Google Scholar
• Qiu W, Huang L, Li Y, et al. Dysregulation of angiopoietin-like-4 associated with hyperlipidemia-induced renal injury by AMPK/ACC pathway. Curr Pharm Des. 2023;29(4):300–309. doi: 10.2174/1381612829666221219123937.
   PubMed Web of Science ®Google Scholar